Immutep Ltd

As of December 31, 2024, Immutep Ltd carries a market capitalization of 531.29M, placing it among publicly traded companies globally. Its enterprise value stands at 373.71M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Immutep Ltd's next confirmed earnings release is scheduled for February 25, 2027.

As of December 31, 2024, Immutep Ltd has 1.46B shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Immutep Ltd maintains a current ratio of 18.86, meaning it holds 18.9x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 22, 2026, Immutep Ltd's stock has declined approximately 92.79% over the past 52 weeks. The 50-day moving average sits at 0.04, while the 200-day moving average is 0.13.

As of December 31, 2024, Immutep Ltd holds 159.26M in cash and equivalents against 1.68M in total debt, resulting in a net debt position of -72.85M. Total book value stands at 172.47M, with working capital of 164.55M providing operational flexibility.

These figures cover the twelve months ended December 31, 2024.

Over the twelve months ended December 31, 2024, Immutep Ltd paid dividends of - - per share. Total shareholder yield is negative at -17.92, meaning Immutep Ltd raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Immutep Ltd's most recent stock split took place on June 5, 2024 with a 758:765 split ratio.